Oncology Market: By Cancer Type; By Therapy Type; & By Region - Forecast 2017-2022

  • ID: 4532466
  • Report
  • Region: Global
  • 143 pages
  • IndustryARC
1 of 3

Oncology refers to the study and treatment of tumors and cancers. Cancer is considered as the second leading cause of death. Cancer types discussed in the report include the breast cancer which is common in women and lung cancer which is common in men owing to tobacco consumptions either as chewing tobacco or smoking tobacco among others

Factors such as rising prevalence of breast cancer, rising disposable income and health concern among people, increased investments in R&D for the latest drug therapies by government and public sectors among others act as drivers for the global oncology market. Besides, a lot of newly launched products are getting pre-market approval which fuels the growth in the oncology market.

Besides high cost of drug development and threat failure, side-effects of anti-cancer drug therapy act as restraints for oncology market during forecast period.

Oncology market report is categorized into two verticals namely: By cancer type and by therapy type. Based on cancer type report is segregated into Breast cancer and lung cancer. On the basis of therapy type market report is divided into medical oncology, radiation oncology and surgical oncology. The medical oncology segment is analyzed to have the largest market share compared to other segments, since, majority of the cancer types are being treated with drugs rather than surgery, even the surgeries were followed by the treatment of cancer cells with drugs. Moreover, oncology market report was segregated based on geography in order to provide intense knowledge about market.

Geographically, North America is overwhelmingly the largest oncology market in 2016 owing to well-developed healthcare infrastructure, increased R&D investments, high health insurance cover for life-threatening diseases in this region. North America was followed by Europe and Asia-Pacific as the second and third largest oncology markets. Whereas, Asia-Pacific is analyzed to be the moderate growing region during the forecast period. Growth in the Asia Pacific market is likely to be driven by high prevalence of cancer in developing countries such as China, Japan, India, new product launches regarding the cancer treatment during the forecast period.

Key players of global oncology market include:

  • F. Hoffmann-La Roche Ltd (Switzerland),
  • Bristol-Myers Squibb (U.S.),
  • Novartis AG (Switzerland),
  • Pfizer (U.S.)
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. ONCOLOGY MARKET OVERVIEW

2. ONCOLOGY MARKET EXECUTIVE SUMMARY

3. ONCOLOGY MARKET LANDSCAPE
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financial Analysis

4. ONCOLOGY MARKET FORCES
4.1. Market Drivers
4.2. Market Restraints & Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Power of Suppliers
4.3.2. Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitution
4.3.5. Degree of Competition

5. ONCOLOGY MARKET– STRATEGIC ANALYSIS
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers & Distributors

6. ONCOLOGY MARKET- BY CANCER TYPE
6.1. Introduction
6.2. Breast Cancer
6.3. Lung Cancer

7. ONCOLOGY MARKET- BY THERAPY TYPE
7.1. Introduction
7.2. Medical Oncology
7.2.1. Chemotherapy
7.2.2. Targeted Therapy
7.2.3. Immunotherapy (biologics therapy)
7.2.4. Hormonal Therapy
7.2.5. Others
7.2.5.1. Blood and Platelet Transfusions
7.2.5.2. Investigational Therapy
7.2.6. Radiation Oncology
7.2.6.1. External Radiation Therapy
7.2.6.2. internal Radiation Therapy
7.2.7. Surgical Oncology
7.2.7.1. Laparoscopic Surgery
7.2.7.2. Robotic Surgery

8. ONCOLOGY MARKET- BY GEOGRAPHY
8.1.Introduction
8.2.North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Others
8.3.Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Russia
8.3.5. Others
8.4.Asia Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Australia
8.4.5. Others
8.5.Rest of the World (RoW)
8.5.1. Middle East & South America
8.5.2. Africa

9. ONCOLOGY MARKET ENTROPY
10.ONCOLOGY MARKET - COMPANY PROFILES
10.1. Aegerion Pharmaceuticals, INC.
10.2. AbbVie
10.3. Ability Pharma
10.4. ACADIA PHARMACEUTICALS
10.5. Amgen Inc.
10.6. Ariad Pharmaceuticals
10.7. Aslan Pharmaceuticals
10.8. Aspen
10.9. AstraZeneca
10.10.Athenex
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll